Cph Group Ag Class A · SIX:CPHN
Cph Group Ag Class A — Investor Day (June 2021)
31 slides from Cph Group Ag Class A's investor day presentation, Jun 14, 2021
Slide 1: Investors' Day: 14 June 2021
Investors’ Day : 14 June 2021 Wolfgang Grimm Head of Packaging © Perlen Packaging AG, Perlen
Slide 2: The Perlen Packaging business model
The Perlen Packaging business model 2 © Perlen Packaging AG, Perlen
Slide 3: Strategy successfully pursued: net sales and EBIT increased
Strategy successfully pursued: net sales and EBIT increased in CHF million 8% p.a. 200 20% 2% p.a. 162 153 153 150 130 15% Net sales raised by 8% p.a. since 2015 116 118 110 119 98 102 106 107 13.3% 100 11.3% 10% Substantial increases in EBIT and EBIT 10.1% 50 3.6% 7.6% 5% margin to currently 13.3%
Slide 4: The global pharmaceutical market and market trends
The global pharmaceutical market and market trends 4 © Perlen Packaging AG, Perlen
Slide 5: The pharma markets in 2020-2025 in USD billion
The pharma markets in 2020-2025 in USD billion 635 445 585 308 370 528 291 290 274 2020 2023 2025 2020 2023 2025 2020 2023 2025 Emerging economies* Europe CAGR 7%-10% USA CAGR 2%-4% CAGR 2%-5% 88 86 84 347 309 113 128 275 100 2020 2023 2025 Japan 2020 2023 2025 2020 2023 2025 CAGR -2%-1% Latin Ameri
Slide 6: Megatrends in pharma
Megatrends in pharma Global population ageing and growth Urbanization Autonomy and self-empowerment Over-60 population trends Civilization and lifestyle illnesses Improved medical and medicinal care Senior-friendly packagings Personalized and dosed packagings Steady trend towards simple oral self-me
Slide 7: The top pharma therapy categories
The top 20 pharma therapy categories Source: IQVIA Feb 2021 7 © Perlen Packaging AG, Perlen
Slide 8: Top home pharma markets, 2015 to 2025 (projected)
Top 20 home pharma markets, 2015 to 2025 (projected) 2015 2020 2025 Rank Country Rank Country Rank Country 1 U.S. 1 US 1 U.S. 2 China 2 China 2 China 3 Japan 3 Japan 3 Japan 4 Germany 4 Germany 4 Germany 5 France 5 France 5 Brazil 6 Italy 6 Italy 6 France 7 U.K. 7 U.K. 7 Italy 8 Spain 8 Brazil 8 U.K
Slide 9: Perlen Packaging: globally interlinked
Perlen Packaging: globally interlinked Perlen Packaging GmbH, Müllheim Competence centre for PVC monofilms Perlen Packaging AG, Perlen Competence centre for barrier films Perlen Packaging LLC, Perlen Packaging Whippany (Suzhou) Co., Ltd. Service and logistics centre Competence centre for NAFTA Perle
Slide 10: Demand for blister pack films for pharmaceutical markets worldwide
Demand for blister pack films for pharmaceutical markets worldwide PVC Pharmaceutical market 2018-2023 CAGR 3-6% Blister packagings CAGR >4-7% PVdC 55% Trend to higher-barrier films PVdC 7-9% p.a. 40% PVC 3-5% p.a. ACLAR PP Other 3% 1% 1% 2018 blister packagings in tonnes, source: MR 1, Perlen Packa
Slide 11: Our competences
Our competences 11 © Perlen Packaging AG, Perlen
Slide 12: A total focus on the pharmaceutical sector
A total focus on the pharmaceutical sector 90% primary pharma packagings (solid dosage forms, blister packs) 10% special applications (ampoule packagings, syringe packagings, medical devices) 12 © Perlen Packaging AG, Perlen
Slide 13: Highest standards maintained
Highest standards maintained ISO 15378 GMP (Switzerland, Germany, China) ISO 9001 US FDA DMF No. 010686, 009072, 030501 China: Center for Drug Evaluation (CDE) ISO 50001 energy management system (Germany) 13 © Perlen Packaging AG, Perlen
Slide 14: References
References Multinational customers Local customers 42% 58% 14 © Perlen Packaging AG, Perlen
Slide 15: A global presence
A global presence 15 © Perlen Packaging AG, Perlen
Slide 16: Packaging: internationalization (sales/representatives 2020)
Packaging: internationalization (sales/representatives 2020) Sales presence in 85 countries through global key account management and 20 regional sales managers Sales via local agents in over 40 countries Pins with flags: production sites 16 © Perlen Packaging AG, Perlen
Slide 17: Packaging: production sites and distribution partners in 2020
Packaging: production sites and distribution partners in 2020 Worldwide 5 production sites (blue, top) and 11 slitting and distribution partners (grey, bottom/right) Perlen Packaging LLC, Perlen Packaging Perlen Packaging Perlen Packaging GmbH, Perlen Packaging Whippany Ltda., Anápolis AG, Perlen Mü
Slide 18: Leadership in innovation
Leadership in innovation 18 © Perlen Packaging AG, Perlen
Slide 19: Always one step ahead. Innovations since 1970
Innovations since 1970 Tristar Generex 1983 2002 Tristar ultra 120 Antimicrobial coating Duplex 2010 1970 2007 PERLAMED™ BLISTair development project Starflex 2017 1997 Identity 2005 Tristar ultra 180 2009 Ultra protect 2012 Always one step ahead. MultiLayer ultra 280 2020 19 © Perlen Packaging AG,
Slide 20: PERLALUX - MultiLayer ultra
PERLALUX® - MultiLayer ultra Barrier protected against mechanical damage Symmetrical layers no curling no “inside/outside” errors Standardized blister pack machine parameters for optimized processing More m2 per kilo 120 – 280 g/m2 back 20 © Perlen Packaging AG, Perlen
Slide 21: The development of barrier packagings
The development of barrier packagings PVC / PVdC PVC / PE / PVdC PVC / PE / PVdC / PE / PVC 1970 - 1990 1983 - 2009 2009 - today High-barrier multilayer-technology products: sales in CHF million 50% 162,3 153,0 153,2 150 40% 130,2 Sales Hohe 119,2 109,7 Barriere 30% 100 CHF million 17,6% Nettoumsatz
Slide 22: Operational leadership
Operational leadership 22 © Perlen Packaging AG, Perlen
Slide 23: The Müllheim (Germany) global monofilm competence centre
The Müllheim (Germany) global monofilm competence centre 3 state-of-the-art PVC calenders compliant with the latest GMP guidelines 35 000 tonnes capacity From homopolymer films to high copolymer films Error identification system Visual surface monitoring Maximum safety and security Automated packagi
Slide 24: Third barrier film centre of excellence currently under construction
Third barrier film centre of excellence currently under construction Perlen Packaging AG global competence centre, Perlen, Switzerland World’s biggest coating plant for thermoformable blister pack materials R&D centre for multilayer and ultra-high-barrier structures Perlen Packaging (Suzhou) Co., Lt
Slide 25: Same technologies and standards worldwide
Same technologies and standards worldwide State-of-the-art coating and laminating facilities Consistent manufacturing processes and quality standards worldwide Specialized technologies to meet pharmaceutical packaging requirements Error identification systems Visual surface monitoring Maximum safety
Slide 26: Continuous Improvement Programme
Continuous Improvement Programme Employees’ knowledge, skills and experience all tapped and fully utilized A key element in the corporate culture Adopted and cultivated throughout the CPH Group © Perlen Packaging AG, Perlen 26
Slide 27: Sustainability and environmental care
Sustainability and environmental care 27 © Perlen Packaging AG, Perlen
Slide 28: Recycling
Recycling What options are available for re-using consumer pharmaceutical waste? Collect and recycle Only possible with mono-material blister packs API contamination: consumer risk evaluation required Limited product portfolio Incinerate with household waste Appropriate air filter technology require
Slide 29: The Perlen Packaging Project Roadmap
The Perlen Packaging Project Roadmap Mono-material blister systems meet the requirements of the circular economy 2021 Full life-cycle assessment (LCA) for thermoformable blister pack solutions Comparative analyses Full range of materials, including PVC PP blister film Bottom film test materials avai
Slide 30: Where to next?
Where to next? Continued profitable growth with a firm focus on the pharmaceutical sector Growth through further market penetration in existing business Market development in regional “white spots” including Africa, the Middle East, India and Australia Original strategy goals of 2012 achieved with
Slide 31: Thank you for your attention
Thank you for your attention © Perlen Packaging AG, Perlen